CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Planned sale See Remarks sold 240 shares at $17.90 ($4,296)
- 4 Planned sale Chief Scientific Officer sold 658 shares at $17.90 ($11,778)
- 4 Planned sale Chief Medical Officer sold 623 shares at $17.90 ($11,152)
- 4 Planned sale Chief Financial Officer sold 568 shares at $17.90 ($10,167)
- 4 Planned sale See Remarks sold 620 shares at $17.90 ($11,098)
- 4 Planned sale Chief Executive Officer sold 9,447 shares at an average $16.91 ($159,775)
- 4 Planned sale President and COO sold 4,570 shares at an average $16.90 ($77,235)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 1 of 34 · 676 filings